0001209191-19-026316.txt : 20190426
0001209191-19-026316.hdr.sgml : 20190426
20190426200136
ACCESSION NUMBER: 0001209191-19-026316
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190425
FILED AS OF DATE: 20190426
DATE AS OF CHANGE: 20190426
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: HSIAO JANE PH D
CENTRAL INDEX KEY: 0001188834
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19437
FILM NUMBER: 19773384
MAIL ADDRESS:
STREET 1: 4400 BISCAYNE BLVD
CITY: MIAMI
STATE: FL
ZIP: 33137
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: TRANSENTERIX INC.
CENTRAL INDEX KEY: 0000876378
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 112962080
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 635 DAVIS DRIVE
STREET 2: SUITE 300
CITY: MORRISVILLE
STATE: NC
ZIP: 27560
BUSINESS PHONE: 919-765-8400
MAIL ADDRESS:
STREET 1: 635 DAVIS DRIVE
STREET 2: SUITE 300
CITY: MORRISVILLE
STATE: NC
ZIP: 27560
FORMER COMPANY:
FORMER CONFORMED NAME: SafeStitch Medical, Inc.
DATE OF NAME CHANGE: 20080211
FORMER COMPANY:
FORMER CONFORMED NAME: CELLULAR TECHNICAL SERVICES CO INC
DATE OF NAME CHANGE: 19930328
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-04-25
0
0000876378
TRANSENTERIX INC.
TRXC
0001188834
HSIAO JANE PH D
4400 BISCAYNE BLVD
MIAMI
FL
33137
1
0
0
0
Common Stock
2019-04-25
4
A
0
20380
A
3603278
D
Common Stock
1257694
I
Hsu Gamma Investments, L.P.
Stock Option Award
1.96
2019-04-25
4
A
0
29104
0.00
A
2029-04-25
Common Stock
29104
29104
D
Represents restricted stock units. Each restricted stock unit represents the right to receive one share of the Registrant's common stock.
The restricted stock units remain subject to forfeiture until the first anniversary of the date of grant or, if earlier, the date of the next annual meeting of stockholders, as long as the reporting person remains in continuous service during the vesting period.
Dr. Hsiao is the general partner of Hsu Gama Investments, LP.
The vesting schedule is 25% of the stock option award on July 1, 2019, October 1, 2019, January 1, 2020 and April 1, 2020. Subject to acceleration of vesting in full upon consummation of a change in control of the registrant.
/s/ Joshua Weingard attorney-in-fact for Jane H. Hsiao
2019-04-26